Approval · Notice of Compliance 28077 · 2022
DUOKOPT: Notice of Compliance 28077
Issued April 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28077
- Date
- April 29, 2022
- Company
- Laboratoires ThéaClermont-Ferrand, Cedex 2, France
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- COSOPT (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUOKOPT | 02526999 | Approved |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML